Jeremy S. Abramson, MD, MMSc, on MCL: Is There Still a Role for ASCT in Mantle Cell Lymphoma?

Posted: Tuesday, February 11, 2025

Jeremy S. Abramson, MD, MMSc, of Massachusetts General Hospital, Harvard Medical School, explores whether there remains a role for autologous stem cell transplantation (ASCT) in the current treatment of patients with mantle cell lymphoma (MCL), in light of the findings from two studies presented at the 2024 ASH Annual Meeting & Exposition: the TRIANGLE trial by the European MCL Network and ECOG-ACRIN EA4151.

---